This symposium will deliver an up to date overview of the latest advances in the management of neuroblastoma, sarcoma and brain tumors, including emerging modalities such as proton therapy, immunotherapy, and CAR T cell therapy. A distinguished faculty of leading experts from nationally recognized cancer centers will present cutting edge technologies and evidence based therapeutic strategies for addressing complex clinical challenges.